BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
See today's BioWorld
Home
» IPO Parade Marches on with Insys Therapeutics' $55M filing
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
IPO Parade Marches on with Insys Therapeutics' $55M filing
March 31, 2011
By
Marie Powers
No Comments
In yet another sign that the biotech industry seems to be tracking the U.S. economy's slow but steady recovery, Insys Therapeutics Inc., of Phoenix, filed with the SEC on Wednesday to raise up to $55 million in an initial public offering (IPO).
BioWorld